02050nam 22004933u 450 991046316260332120210106230629.01-78084-195-7(CKB)2670000000391294(EBL)1179641(OCoLC)851970663(SSID)ssj0001599925(PQKBManifestationID)16306389(PQKBTitleCode)TC0001599925(PQKBWorkID)14892908(PQKB)11551135(MiAaPQ)EBC1179641(Au-PeEL)EBL1179641(EXLCZ)99267000000039129420131021d2013|||| u|| |engur|n|---|||||txtccrCurrent & Emerging Treatments for Immune Thrombocytopenia[electronic resource]1st ed.London Future Medicine Ltd20131 online resource (135 p.)Description based upon print version of record.1-78084-197-3 Title page; Copyright form; Contents; Foreword. Addressing current treatment options for autoimmune thrombocytopenia; 1. Pathogenesis; 2. Symptoms and diagnosis; 3. Treatment guidelines & algorithm; 4. Steroids; 5. Immunoglobulins; 6. Immunosuppressants; 7. Thrombopoietin receptor agonists; 8. Platelet transfusion; 9. Surgical approach; IndexImmune thrombocytopenia (ITP) is the best characterized human autoimmune disease and affects approximately 5% of the world's population. Clinically, it is defined by a low platelet count and increased bleeding risk. In this book, international experts provide a rounded overview of the disease and its management.Electronic books.616.15Salama Abdulgabar1047778Salama AbdulgabarAU-PeELAU-PeELAU-PeELBOOK9910463162603321Current & Emerging Treatments for Immune Thrombocytopenia2475618UNINA